The global female infertility diagnosis and treatment market is projected to grow at a CAGR of 4%, during the forecast period. Increasing infertility and changing lifestyle to drive the growth of the global female infertility diagnosis and treatment market. For instance, as per the estimation of the Centers for Disease Control and Prevention (CDC), in 2017, in the US, around 12.1% of women aged between 15-44 suffer from impaired fecundity, whereas, nearly 6.7% of married women in the same age group are infertile. This, in turn, is expected to propel the demand for female infertility diagnosis and treatment.
Request a free sample of our report on Female Infertility Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/female-infertility-market-size
Furthermore, the rising trends of surrogacy, growing infertility rate among females, new technologies to avoid multiple embryo implants are estimated to be the major factors that are contributing towards the growth of the market. However, there are certain factors that are restraining the growth of the market, such as the high cost of infertility treatment, low accuracy rate of the treatment. Moreover, the social stigma related to the infertility treatment is another factor that may hinder the global female infertility diagnosis and treatment market across the globe.
A full report of Female Infertility Diagnosis and Treatment Market is available at: https://www.omrglobal.com/industry-reports/female-infertility-market-size
Global Female Infertility Diagnosis and Treatment Market Segmentation
By Diagnosis
Ovulation Testing
Hysterosalpingography (HSG)
Hysteroscopy
Imaging Testing
Ovarian Reserve Testing
Hormonal Level Testing
Genetic Testing
Others (Laparoscopy)
By Treatment
Drugs
Surgery
Intrauterine Insemination (IUI)
Assisted Reproductive Technology (ART)
By End-User
Hospitals and Clinics
Homecare
Pathology and Diagnostic Centers
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles
Bayer AG
Clearblue, a company of SPD Swiss Precision Diagnostics GmbH
Cook Medical, Inc.
Eli Lilly & Co.
Esco Group
Fairhaven Health, LLC
Ferring B.V.
FIRST RESPONSE, a division of Church & Dwight Co., Inc.
FUJIFILM Irvine Scientific, Inc.
Genea Ltd.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/female-infertility-market-size
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email:
[email protected]
Contact no: +91 780-304-0404